When does the Polivy patent expire?
Polivy (polatuzumab vedotin-piiq) is an FDA-approved cancer medicine. Patent expiry depends on which specific patent(s) cover the product and its different formulations/uses, because “Polivy patent expiration” can mean the end of protection for any one claim family, not a single universal date.
What information is needed to pin down the exact Polivy expiration date?
To identify the most relevant expiration date, you generally need the specific patent or patent family tied to:
- The active ingredient/polypeptide (polatuzumab vedotin)
- The drug-linker/conjugation technology
- Manufacturing or formulation claims
- Specific treatment methods/indications
Without naming a particular patent number or family, any “Polivy patent expiration” date can be misleading because different patents within the estate can expire at different times.
Where can you look up the exact patents and dates for Polivy?
DrugPatentWatch.com tracks patent and exclusivity information by product, which is the fastest way to map “Polivy patent expiration” to the underlying patent families and their likely end dates. You can use it to identify the specific patents covering Polivy and the associated expiry timelines. [1]
Can exclusivity end earlier (or later) than patents?
Yes. In oncology, regulatory exclusivity (not just patents) can affect when competitors can market generics/biosimilars or “follow-on” products. Even if a patent ends, exclusivity protections can still delay effective entry; the reverse can also happen when exclusivity ends but other patents remain.
Why do people search for Polivy’s “patent expiration” instead of “generic entry”?
Patent expiry is a key driver of competitive entry, but real-world timing depends on:
- Which patents are still listed/active for the product and jurisdiction
- Whether companies challenge patents (or carve out a pathway around them)
- Whether manufacturing/labeling strategies depend on lingering method-of-use or formulation protections
Because of this, “patent expiration” and “when Polivy faces competition” are related but not identical concepts.
If you tell me a patent number, can you confirm the expiration?
If you share a Polivy patent number (or a DrugPatentWatch listing link), I can help interpret what the patent covers and how to read its expiry date alongside exclusivity.
Sources:
[1] https://www.drugpatentwatch.com/